41239-40-1

Usage

Uses

Used in Pharmaceutical Industry:
N-METHYL-2-MORPHOLIN-4-YLETHANAMINE is utilized as a building block in the synthesis of various pharmaceuticals. Its unique structure allows it to be incorporated into the development of new drugs, enhancing their efficacy and pharmacological properties.
Used in Agrochemical Industry:
In the agrochemical sector, N-METHYL-2-MORPHOLIN-4-YLETHANAMINE serves as a key component in the creation of agrochemicals. Its role in this industry is crucial for the development of effective and environmentally friendly products for agricultural use.
Used in Organic Chemistry:
N-METHYL-2-MORPHOLIN-4-YLETHANAMINE is employed as a reagent in organic chemistry reactions. It is particularly useful in the formation of amide and ester bonds, which are fundamental in the synthesis of a wide array of organic compounds.
Used in Research and Development:
N-METHYL-2-MORPHOLIN-4-YLETHANAMINE is also valuable in research and development settings, where it can be explored for new applications and to understand its chemical properties and potential interactions with other molecules. Its use in this context aids in the advancement of scientific knowledge and the discovery of innovative applications.

InChI:InChI=1/C7H16N2O/c1-8-2-3-9-4-6-10-7-5-9/h8H,2-7H2,1H3

Upstream product

• 3647-69-6 4-(2-chloroethyl)morpholine hydrochride 
• 74-89-5 methylamine 
• 29336-61-6 methyl-(2-morpholin-4-yl-ethyl)-phosphoramidic acid diethyl ester 
• 110-91-8 morpholine 
• 2038-03-1 4-(2-AMINOETHYL)MORPHOLINE 
• 24424-99-5 di-tert-butyl dicarbonate 
• 7732-18-5 water 
• 78375-50-5 N-(2-morpholinoethyl)formamide 

Downstream Products

• 21269-20-5 1-(2-chloro-phenoxy)-3-[methyl-(2-morpholin-4-yl-ethyl)-amino]-propan-2-ol 
• 96262-16-7 2-ethoxy-N-methyl-N-(2-morpholin-4-yl-ethyl)-2,2-diphenyl-acetamide 
• 37109-11-8 2-hydroxy-N-methyl-N-(2-morpholin-4-yl-ethyl)-2-phenyl-2-thiophen-2-yl-acetamide 
• 1101119-08-7 N'-((5-cyanopyrazolo[1,5-a]pyridin-3-yl)methylene)-N-methyl-2-(methyl(2-morpholinoethyl)amino)-5-nitrobenzenesulfonohydrazide hydrochloride 

Relevant academic research and scientific papers

COMPOUNDS THAT INHIBIT MCL-1 PROTEIN

Provided herein are myeloid cell leukemia 1 protein (Mcl-1) inhibitors, methods of their preparation, related pharmaceutical compositions, and methods of using the same. For example, provided herein are compounds of Formula (I), or a stereoisomer thereof; and pharmaceutically acceptable salts thereof and pharmaceutical compositions containing the compounds. The compounds and compositions provided herein may be used, for example, in the treatment of diseases or conditions, such as cancer.

Compounds and methods for inhibiting phosphate transport

Compounds having activity as phosphate transport inhibitors, more specifically, inhibitors of intestinal apical membrane Na/phosphate co-transport, are disclosed. The compounds have the following structure (I): including stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, wherein X, Y, A, R1 and R2 are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.

SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1

Provided herein are small molecule neurotensin receptor agonists, compositions comprising the compounds, and methods of using the compounds and compositions comprising the compounds.

KINASE INHIBITORS

Compounds of formula (I) or a pharmaceutically acceptable salt thereof: formula (I) wherein R2, W, A, Y and R1 are as defined in the specification, are p38 MAPK inhibitors, useful as anti-inflammatory agents in the treatment of, inter alia, diseases of the respiratory tract.

KINASE INHIBITORS

Compounds of formula (I) and pharmaceutically acceptable salts thereof: wherein R2, W, A, Y and R1 are as defined in the specification, are p38 MAPK inhibitors, and are useful as anti-inflammatory agents in the treatment of, inter alia, diseases of the respiratory tract.

C-4" POSITION SUBSTITUTED MACROLIDE DERIVATIVE

A macrolide compound represented by the formula (I) effective against erythromycin resistant bacteria (for example, resistant pneumococci, streptococci and mycoplasmas).

COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT

Compounds having activity as phosphate transport inhibitors, more specifically, inhibitors of intestinal apical membrane Na/phosphate co-transport, are disclosed. The compounds have the following structure (I): including stereoisomers, pharmaceutically ac

COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT

Compounds having activity as phosphate transport inhibitors, more specifically, inhibitors of intestinal apical membrane Na/phosphate co-transport, are disclosed. The compounds have the following structure (I): including stereoisomers, pharmaceutically ac

COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT

Compounds having activity as phosphate transport inhibitors, more specifically, inhibitors of intestinal apical membrane Na/phosphate co-transport, are disclosed. The compounds have the following structure (I): including stereoisomers, pharmaceutically ac

INHIBITORS OF ANTHRAX LETHAL FACTOR

Methods, compounds and compositions for preventing and treating anthrax infections by inhibiting Anthrax Lethal Factor (LF) activity.